Oppenheimer Raises Price Target on Capital One Financial (COF) Following 3Q Report

Pre-Open Stock Movers 10/26: (OGXI) (AKAM) (IRBT) Higher; (EW) (NUVA) (P) (CMG) (AAPL) Lower (more...)

October 26, 2016 9:15 AM EDT

Today's Pre-Open Stock Movers

OncoGenex Pharmaceuticals, Inc. (Nasdq: OGXI) 32.3% HIGHER; announced positive survival results from the final analysis of the Phase 2 Borealis-2 trial of apatorsen in combination with docetaxel treatment that enrolled 200 patients with metastatic bladder cancer whose disease had progressed following first-line platinum-based chemotherapy. Patients who received apatorsen treatment experienced a 20% reduction in risk of death, compared to patients receiving docetaxel alone (HR=.80; 95% CI: 0.65-0.98; p=0.078). The primary analysis was a superiority test of overall survival, performed at a one-sided 0.10 significance level using a stratified log-rank test. The trial was conducted by... More

Jefferies Remains Sidelined on Capital One Financial (COF) Following EPS Beat

October 26, 2016 9:12 AM EDT

Jefferies reiterated a Hold rating and $69.00 price target on Capital One Financial (NYSE: COF) following the company's 3Q earnings report. COF reported EPS of $2.03, ahead of the consensus estimate of $1.94.

Analyst John Hecht commented, "COF reported adjusted 3Q16 EPS of $2.03 versus our estimate... More

After-Hours Movers 10/25: (OGXI) (AKAM) (VRTX) Higher; (EW) (NUVA) (CMG) (AAPL) Lower (more...)

October 25, 2016 6:03 PM EDT

Today's After-Hours Movers

OncoGenex Pharmaceuticals, Inc. (Nasdq: OGXI) 35% HIGHER; announced positive survival results from the final analysis of the Phase 2 Borealis-2 trial of apatorsen in combination with docetaxel treatment that enrolled 200 patients with metastatic bladder cancer whose disease had progressed following first-line platinum-based chemotherapy. Patients who received apatorsen treatment experienced a 20% reduction in risk of death, compared to patients receiving docetaxel alone (HR=.80; 95% CI: 0.65-0.98; p=0.078). The primary analysis was a superiority test of overall survival, performed at a one-sided 0.10 significance level using a stratified log-rank test. The trial was conducted by the Hoosier... More

Capital One Financial (COF) Tops Q3 EPS by 9c

October 25, 2016 4:09 PM EDT

Capital One Financial (NYSE: COF) reported Q3 EPS of $2.03, $0.09 better than the analyst estimate of $1.94. Revenue for the quarter came in at $6.46 billion versus the consensus estimate of $6.42 billion.

For earnings history and earnings-related data on Capital One Financial (COF) click here.

... More

Capital One (COF) volatility flat into Q3 and outlook

October 25, 2016 5:30 AM EDT

Capital One Financial (NYSE: COF) 30-day option implied volatility of 26 compares to its 52-week range of 19 to 45 into Q3.

... More

Trading Radar for 10/25: Apple (AAPL), Caterpillar (CAT), Chipotle (CMG), Under Armour (UA), Juniper (JNPR) Report

October 24, 2016 2:16 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
9:00am EDT

Case-Shiller 20-City Index - Street sees 5.1%FHFA Housing Price Index - no Street consensus

Earnings:

3M Co. (NYSE: MMM) - consensus EPS $2.13
AK Steel (NYSE: AKS) - consensus EPS $0.13
AVANGRID, Inc. (NYSE: AGR) - consensus EPS $0.59
Allegheny Technologies (NYSE: ATI) - consensus loss $0.10
Allegiance... More